Upregulation of enzymatic activity by interleukin-1 in osteoarthritis

Biomedicine and Pharmacotherapy

Volumn 51, Issue 2, 1997, Pages 58-62

  Chevalier, X ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

cartilage; interleukin 1; metalloproteases; osteoarthritis

Indexed keywords

METALLOPROTEINASE; PHOSPHOLIPASE A2; RECOMBINANT INTERLEUKIN 1;

ARTICULAR CARTILAGE; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRAARTICULAR DRUG ADMINISTRATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SYNOVIAL FLUID;

EID: 0031048246     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)87727-X     Document Type: Article

References (34)

1. 1 Maroudas A, Mizrahi J, Katz EP, Wachtel EJ, Soudry M. Physiochemical properties and functional behaviour of normal and osteoarthritic human cartilage. In: Kuettner K, Schleyerbach R, Hascall VC, Peyron JJ, eds. Articular Cartilage Biochemistry, 3rd edn. New York: Raven Press, 1986
2. 2 Heinegard D, Oldberg A. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J 1989;3:2042-54
3. 3 Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. TIG 1990;6:121-3
4. 4 Dean J, Martel-Pelletier J, Pelletier JP et al. Evidence for metalloprotease and metalloprotease inhibitor imbalance in human osteoarthritic cartilage. Arthritis Rheum 1990;33: 1466-76
5. 5 Chubinskaya S, Huch K, Mikecz K et al. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1β in human normal cartilage from knee and ankle joints. Lab Invest 1996;74:232-40
6. 6 Wernicke D, Seyfert C, Hinzmann B, Gromnica-Ihle E. Cloning of collagenase 3 in the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 1996;23:590-5
7. 7 Huet G, Flipo RM, Colin C et al. Stimulation of latent cysteine proteinase activity by tumor necrosis factor and interleukin-1α. Arthritis Rheum 1993;36:772-8
8. 8 Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991;5:2145-54
9. 9 Martel-Pelletier J, Zarafullah M, Komada S, Pelletier JP. In vitro effects of interleukin-1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J Rheumatol 1991;(suppl 27) 18:80-4
10. 10 Pelletier JP, Mineau F, Faure MP, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition (TIMP) of metalloproteases in early lesions of experimental osteoarthritis. Arthritis Rheum 1990;33: 1466-76
11. 11 Dinarello C. Biology of interleukin 1. FASEB J 1988;2: 108-15
12. 12 Dayer JM. Chronic inflammatory joint diseases: natural inhibitors of interleukin 1 and tumor necrosis factor. J Rheumatol 1991;(suppl 27)18:71-5
13. 13 Vincenti MP, Coon CI, White LA, Barchowsky A, Brinckerhoff CE. Src-related tyrosine kinases regulate transcriptional activation of the interstitial collagenase gene, MMP-1, in interleukin-1 stimulated synovial fibroblasts. Arthritis Rheum 1996;39:547-82
14. 14 Häuselmann HJ, Flechtenmacher J, Michal L et al. The superficial layer of human articular cartilage is more susceptible to interleukin-1 induced damage than the deeper layers. Arthritis Rheum 1996;39:478-88
15. 15 Saklatlvala J. Regulation of chondrocytes by cytokines. In: Adolphe M, ed. Biological Regulation of Chondrocytes. Boca Raton: CRC Press, 1992
16. 16 Shinmei M, Masuda K, Kikuchi T, Shimonura Y, Okada Y. Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Rheumatol 1991;(suppl 27) 18:89-91
17. 17 Goldring MB, Birkhead JR, Suen LF et al. Interleukin-1β modulates gene expression in immortalized human chondrocytes. J Clin Invest 1994;94:2307-16
18. 18 Lafyatis R, Kim SJ, Angel P et al. Interleukin-1 stimulates and all-trans retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1 binding site. Mol Endocrinol 19904:973-80
19. 19 Buttle DJ, Handley CJ, Ilic M, Saklatvala J, Murata M, Barret AJ. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Arthritis Rheum 1993;12: 1709-11
20. 20 Zhao-Ping L, Hakala BE, Mort JS, Recklies AD. Modulation of the catabolic effects of interleukin-1β on human articular chondrocytes by transforming growth factor β. J Cell Physiol 1996;166:351-9
21. 21 Mort JS, Dodge GR, Roughley PJ et al. Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix 1993;13:95-102
22. 22 Angel J, Berenbaum F, Nevalaienen T, Masliah J, Fournier C. Interleukin-1 induced prostaglandin E2 biosynthesis in human synovial cells involves activation of cytosolic phospholipase A2 and cyclooxygenase 2. Eur J Biochem 1994;226:125-31
23. 23 Yaron I, Meyer FA, Dayer JM, Bleiberg I, Yaron M. Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit in human articular cartilage. Arthritis Rheum 1989;32:173-80
24. 24 Seid JM, Rahman S, Graveley R et al. The effect of interleukin-1 on cytokine gene expression in cultured articular chondrocytes analyzed by messenger RNA phenotyping. Arthritis Rheum 1993;36:35-43
25. 25 Chin JIAE, Hatfiled A, Krezecki RF, Herblin WF. Interactions between interleukin-1 and basic fibroblast growth factor on articular chondrocytes. Arthritis Rheum 1991; 34:314-24
26. 26 Kerr LD, Miller DB, Matrisian LM. TGFβ inhibition of stromelysin gene expression is mediated through a fos binding sequence. Cell 1990;61:267-78
27. 27 Guerne PA, Carson DA, Lotz M. Interleukin-6 production by human articular chondrocytes: modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 1990;144:499-505
28. 28 Homandberg GA, Meyer R, Xie DL. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 1992;267:3597-604
29. 29 Olliviere F, Gubler U, Towle C, Laurencin C, Treadwell BV. Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of articular matrix degradation. Biochem Biophys Res Commun 1986;141:904-11
30. 30 Pettipher ER, Higgs GA, Henderson B. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986;83:8749-56
31. 31 Page-Thomas DP, King B, Stephans T, Dingle JT. In vivo studies of cartilage regeneration after damage induced by catabolin/IL-1. Ann Rheum Dis 1991;50:75-80
32. 32 Van den Berg WB, Joosten LAB, Helsen MA, van Lemt PLEM, van den Loo FAJ. Cytokine profile dependent on the type of arthritis: dominant role of IL-1 in cartilage destruction. Arthritis Rheum 1994;37(9)S193:208
33. 33 Dudler J, Raz E, Lotz M. Inhibition of IL-1 effects by a soluble IL-1 receptors/IG fusion protein. Arthritis Rheum 1994;37(9)S340:1073
34. 34 Makarov SS, Olsen JC, Johnston WN et al. Suppression of experimental arthritis by gene transfer of interleukin-1 receptor antagonist cDNA. Proc Natl Acad Sci USA 1996;93:402-6